M. Masters

Masters Speciality Pharma is a UK-based specialty pharmaceutical company focused on sourcing, licensing, distributing, and commercializing life-saving medicines in emerging markets. The company partners with life sciences companies to bring specialty medicines to hospitals, clinics, and government organizations, with particular emphasis on rare and orphan diseases as well as oncology, haematology, and pain management. Masters appears to operate primarily as a commercial-stage specialty pharma and access/distribution business rather than a discovery-stage biotech developer. Publicly referenced products include Siklos for sickle cell disease in the UK and Brazil and Spinraza through early access activity in Brazil. The company highlights a global supply network and regulatory/commercial capabilities across Latin America, the Caribbean, the Middle East, and other emerging markets.